Aliases & Classifications for Pollen Allergy

MalaCards integrated aliases for Pollen Allergy:

Name: Pollen Allergy 12 15
Hay Fever 73

Classifications:



External Ids:

Disease Ontology 12 DOID:0060497
UMLS 73 C0018621

Summaries for Pollen Allergy

Disease Ontology : 12 A respiratory allergy triggered by pollen.

MalaCards based summary : Pollen Allergy, also known as hay fever, is related to esophagitis, eosinophilic, 1 and rhinitis, and has symptoms including tinnitus, rhinorrhea and snoring. An important gene associated with Pollen Allergy is CD164 (CD164 Molecule), and among its related pathways/superpathways are Innate Immune System and Pathways in cancer. The drugs Montelukast and Cetirizine have been mentioned in the context of this disorder. Affiliated tissues include skin, testes and eye, and related phenotypes are hematopoietic system and immune system

Wikipedia : 76 Allergic rhinitis, also known as hay fever, is a type of inflammation in the nose which occurs when the... more...

Related Diseases for Pollen Allergy

Diseases related to Pollen Allergy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 117)
# Related Disease Score Top Affiliating Genes
1 esophagitis, eosinophilic, 1 30.5 IL13 IL5
2 rhinitis 30.0 EPX ICAM1 IL13 IL4R IL5 RNASE3
3 respiratory allergy 29.9 IL13 IL3 IL4R IL5 RNASE3
4 food allergy 29.8 EPX FOXP3 IL13 IL5 RNASE3
5 allergic rhinitis 29.7 EPX ICAM1 IL13 IL4R IL5 MPO
6 allergic asthma 29.6 EPX IL13 IL4R IL5 RNASE3
7 asthma 29.0 ADRB2 EPX ICAM1 IL13 IL3 IL4R
8 timothy grass allergy 11.2
9 loeffler endocarditis 10.2 IL5 RNASE3
10 autoimmune enteropathy 10.2 FOXP3 ICAM1
11 cough variant asthma 10.2 IL5 RNASE3
12 cow milk allergy 10.2 IL5 RNASE3
13 milk allergy 10.2 IL5 RNASE3
14 esophagitis 10.2
15 cytokine deficiency 10.2 IL13 IL5
16 kimura disease 10.2 IL5 RNASE3
17 angioimmunoblastic lymphadenopathy with dysproteinemia 10.2 IL13 IL5
18 respiratory syncytial virus infectious disease 10.2 IL13 IL5
19 actinic prurigo 10.2 ICAM1 IL13
20 nickel allergic contact dermatitis 10.2 IL13 IL5
21 trichuriasis 10.2 IL13 RNASE3
22 nut allergy 10.2 FOXP3 IL5
23 drug allergy 10.2 IL4R IL5
24 seborrheic infantile dermatitis 10.2 IL3 IL5
25 angiostrongyliasis 10.2 IL13 IL5
26 strongyloidiasis 10.2 IL13 IL5
27 lichen disease 10.2 FOXP3 ICAM1
28 ascaris lumbricoides infection 10.2 IL13 IL5
29 eosinophilic meningitis 10.2 IL13 IL5
30 penicillin allergy 10.2 IL13 IL4R
31 hypereosinophilic syndrome, idiopathic 10.2 IL3 IL5
32 eosinophilic granuloma 10.2 EPX RNASE3
33 intestinal schistosomiasis 10.2 IL13 IL5
34 beta-lactam allergy 10.2 IL13 IL4R
35 chronic tic disorder 10.1 IL13 IL5
36 chronic eosinophilic pneumonia 10.1 ICAM1 IL5 RNASE3
37 conjunctival nevus 10.1 EPX RNASE3
38 wells syndrome 10.1 IL5 RNASE3
39 hepatitis 10.1
40 urticaria 10.1
41 enterobiasis 10.1 IL13 IL5
42 sinusitis 10.1 IL4R IL5 RNASE3
43 schistosomiasis 10.1 IL13 IL5 RNASE3
44 paragonimiasis 10.1 IL13 IL5 RNASE3
45 latex allergy 10.1 IL13 IL5 RNASE3
46 autoimmune disease of endocrine system 10.1 FOXP3 ICAM1
47 conjunctival disease 10.1 IL13 IL5 RNASE3
48 parasitic helminthiasis infectious disease 10.1 IL13 IL5 RNASE3
49 night blindness, congenital stationary, type 1a 10.1 IL13 IL5
50 lipoid nephrosis 10.1 IL13 IL4R

Graphical network of the top 20 diseases related to Pollen Allergy:



Diseases related to Pollen Allergy

Symptoms & Phenotypes for Pollen Allergy

UMLS symptoms related to Pollen Allergy:


tinnitus, rhinorrhea, snoring, coughing, sore throat, vertigo/dizziness, equilibration disorder

MGI Mouse Phenotypes related to Pollen Allergy:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.61 ADRB2 EPX FOXP3 ICAM1 IL13 IL4R
2 immune system MP:0005387 9.28 ADRB2 EPX FOXP3 ICAM1 IL13 IL4R

Drugs & Therapeutics for Pollen Allergy

Drugs for Pollen Allergy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 186)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Montelukast Approved Phase 4,Phase 3,Phase 2,Not Applicable 158966-92-8 5281040
2
Cetirizine Approved Phase 4,Phase 3,Phase 2,Not Applicable 83881-51-0 2678
3
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-45-6, 75614-87-8 774
4
Nitric Oxide Approved Phase 4 10102-43-9 145068
5
Fluticasone Approved, Experimental Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 90566-53-3 62924
6
Azelastine Approved Phase 4,Phase 3,Phase 2,Not Applicable 58581-89-8 2267
7
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 90-82-4 7028
8
Xylometazoline Approved, Investigational Phase 4,Not Applicable 526-36-3 5709
9
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
10
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
11
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
12
mometasone furoate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83919-23-7
13
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
14
Ephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 299-42-3 9294
15
Phenylephrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 59-42-7 6041
16
Oxymetazoline Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 1491-59-4 4636
17
Loratadine Approved, Investigational Phase 4,Phase 3,Phase 2 79794-75-5 3957
18
Levocetirizine Approved Phase 4,Phase 3,Phase 2,Not Applicable 130018-77-8 1549000
19
Desloratadine Approved, Investigational Phase 4,Phase 3,Phase 2 100643-71-8 124087
20
Fexofenadine Approved, Investigational Phase 4,Phase 3,Phase 2 83799-24-0 3348
21
Diphenhydramine Approved, Investigational Phase 4 147-24-0, 58-73-1 3100
22
Promethazine Approved, Investigational Phase 4 60-87-7 4927
23
Epinastine Approved, Investigational Phase 4,Phase 3,Phase 2 80012-43-7 3241
24
Ergocalciferol Approved, Nutraceutical Phase 4 50-14-6 5280793
25
Vitamin D3 Approved, Nutraceutical Phase 4 67-97-0 5280795 6221
26
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4 1406-16-2
27
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
28
Tranilast Investigational Phase 4 53902-12-8 93543
29 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Not Applicable
30 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
31 Hormone Antagonists Phase 4,Phase 3,Phase 2,Not Applicable
32 Leukotriene Antagonists Phase 4,Phase 3,Phase 2,Not Applicable
33 Histamine H1 Antagonists, Non-Sedating Phase 4,Phase 3,Phase 2,Not Applicable
34 Anti-Allergic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
35 Histamine Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
36 Respiratory System Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
37 Hormones Phase 4,Phase 3,Phase 2,Not Applicable
38 Histamine H1 Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
39 Anti-Asthmatic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
40
Histamine Phosphate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-74-1 65513
41 Lipoxygenase Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
42 Autonomic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
43 Bronchodilator Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
44 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
45 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
46 Dermatologic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
47 Vasoconstrictor Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
48 Nasal Decongestants Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
49 Antineoplastic Agents, Hormonal Phase 4
50 Methylprednisolone acetate Phase 4

Interventional clinical trials:

(show top 50) (show all 424)
# Name Status NCT ID Phase Drugs
1 Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis Unknown status NCT00488176 Phase 4 montelukast;cetirizine;montelukast and cetirizine;placebo
2 POLlinosis and Exhaled Breath Temperature Unknown status NCT01785394 Phase 4 5 grass allergen extract
3 Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis Unknown status NCT02014623 Phase 4 Control
4 Evaluating Factors Involved in Dymista's Superior Clinical Efficacy to Fluticasone Propionate in the Treatment of Seasonal Allergic Rhinitis Unknown status NCT02402465 Phase 4 Placebo;Fluticasone propionate;Fluticasone/Azelastine nasal spray
5 4"S" - Seasonal Symptoms Suppression Study Unknown status NCT02557269 Phase 4 Xylometazoline - intranasal application;Azelastine - intranasal application;Mometasone furoate - intranasal application;Hydroxyl-propyl-methyl cellulose powder - intranasal application;Bilastine 20 mg;Prednisolone 5 mg
6 Can we Help People With the Oral Allergy Syndrome Eat Fresh Fruit? Unknown status NCT01431859 Phase 4
7 Fluticasone Furoate Treatment of Daytime Somnolence and Cognitive Performance in Seasonal Allergic Rhinitis Completed NCT00997620 Phase 4 Fluticasone furoate Nasal Spray 110 mcg;Placebo
8 Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms Completed NCT00460538 Phase 4
9 Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial Completed NCT00691665 Phase 4 Olopatadine HCL Nasal Spray, 0.6%;Fluticasone Propionate Nasal Spray, 50 mcg
10 A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis Completed NCT00561717 Phase 4 Azelastine and placebo;Loratadine and Placebo;Cetirizine and Placebo;Placebo and Placebo (spray and Tablet)
11 A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis Completed NCT00653224 Phase 4 levocetirizine dihydrochloride;placebo
12 A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis Completed NCT00621959 Phase 4 levocetirizine dihydrochloride;placebo
13 Preference for Clarinex Tablets vs Allegra Tablets in Patients With Seasonal Allergies (P03178) Completed NCT00794768 Phase 4 desloratadine 5 mg;fexofenadine
14 Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03179) Completed NCT00794248 Phase 4 desloratadine 5 mg;fexofenadine
15 Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03177) Completed NCT00783133 Phase 4 Desloratadine 5 mg;fexofenadine
16 Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit Completed NCT00637611 Phase 4 Fexofenadine HCl
17 Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED) Completed NCT00358527 Phase 4 Mometasone Furoate Nasal Spray (MFNS)
18 Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR) (Study P04054) Completed NCT00783146 Phase 4 desloratadine;fexofenadine;placebo
19 Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED) Completed NCT00783211 Phase 4 desloratadine;fexofenadine;placebo
20 Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836) Completed NCT00867191 Phase 4 Placebo;Desloratadine
21 This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED) Completed NCT00491504 Phase 4 Mometasone Furoate Nasal Spray
22 Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR) Completed NCT02932774 Phase 4 Cetirizine;Loratadine
23 Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid Completed NCT00845195 Phase 4 Olopatadine HCl Nasal Spray, 0.6%;Azelastine HCl Nasal Spray, 0.1%
24 Vitamin D Plus Fluticasone Propionate Completed NCT01103934 Phase 4 Vitamin D3;Placebo;Fluticasone Propionate
25 Efficacy of 2LALERG (Homeopathic Drug) in Allergic Rhinitis Related to Grass Pollen Completed NCT02690935 Phase 4 2LALERG;Placebo
26 Study of Nasal Symptom Relief and Side Effects in Hayfever Patients Treated With Aerius (Desloratadine)(P03442) Completed NCT00805584 Phase 4 desloratadine
27 POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis) Completed NCT00160537 Phase 4 Levocetirizine
28 A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712) Completed NCT01469234 Phase 4 loratadine;fexofenadine;placebo to loratadine;placebo to fexofenadine
29 Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive Subjects Completed NCT00295022 Phase 4 Placebo;Montelukast;Levocetirizine
30 Effects of Sublingual Immunotherapy on Grasspollen Allergy Completed NCT00150514 Phase 4 Oralgen
31 A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis Completed NCT01916226 Phase 4 FPNS;FPNS Placebo;Cetirizine;Cetirizine Placebo
32 To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses Completed NCT00648973 Phase 4 Diphenhydramine 50 mg;Diphenhydramine 25 mg;Pseudoephedrine 120 mg
33 Comparison of Perennial and Preseasonal Subcutaneous Immunotherapy Completed NCT01555736 Phase 4 grass (80%) and rye (20%) pollens allergoids
34 Effectiveness Of Therapy With A Thermal Water Nasal Aerosol In Children With Seasonal Allergic Rhinitis Completed NCT01326247 Phase 4
35 Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis Completed NCT00542607 Phase 4 levocetirizine dihydrochloride
36 Study of the Effect of Fluticasone Furoate Nasal Spray on Spring Allergy Eye Symptoms Completed NCT00891436 Phase 4 Fluticasone furoate nasal spray;Placebo nasal spray
37 Allergic Rhinitis Changes the Sinus Microbiome Completed NCT01852513 Phase 4 QNASL;Placebo nasal spray
38 MP-AzeFlu Allergen Chamber - Onset of Action Study Completed NCT03004131 Phase 4 Azelastine hydrochloride + fluticasone propionate nasal spray;Placebos;fluticasone propionate nasal spray + loratadine
39 Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms Completed NCT01007253 Phase 4 PL nasal spray;fluticasone furoate (FF);PL eye drops;olopatadine (OLO)
40 Intranasal Steroids and the Nasal Ocular Response Completed NCT00473915 Phase 4 fluticasone furoate
41 Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel Completed NCT00637455 Phase 4 fexofenadine HCl
42 Regulatory Lymphocytes in Patients Treated With Specific Immunotherapy Completed NCT01475188 Phase 4 Allergovit
43 Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS Completed NCT00539006 Phase 4 FPNS;FFNS;placebo FPNS;placebo FFNS
44 Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS Completed NCT00519636 Phase 4 FPNS;FFNS;placebo FFNS;placebo FPNS
45 Tolerability of Grazax in Patients With Hayfever in Real Life Settings Completed NCT01433510 Phase 4 Grazax
46 Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR) Completed NCT00818805 Phase 4 Olopatadine 0.1%;Tranilast 0.5%;Placebo (Olopatadine);Placebo (Tranilast)
47 Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine Completed NCT00502775 Phase 4 fluticasone furoate, fexofenadine
48 Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With AR. RinASol- Pilot Study Completed NCT02729012 Phase 4 hypertonic saline solution (NACL 3%+NAHCO3)
49 Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine Completed NCT00435461 Phase 4 Fluticasone furoate and fexofenadine
50 Study Of Patients With Allergic Rhinitis And Asthma Completed NCT00296530 Phase 4 fluticasone propionate/salmeterol;fluticasone propionate;montelukast

Search NIH Clinical Center for Pollen Allergy

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Genetic Tests for Pollen Allergy

Anatomical Context for Pollen Allergy

MalaCards organs/tissues related to Pollen Allergy:

41
Skin, Testes, Eye, T Cells, Bone, B Cells, Lung

Publications for Pollen Allergy

Articles related to Pollen Allergy:

(show top 50) (show all 1148)
# Title Authors Year
1
Long-term effect of monophosphoryl lipid A adjuvanted specific immunotherapy in patients with grass pollen allergy. ( 29562801 )
2018
2
Thunderstorm asthma: controlling (deadly) grass pollen allergy. ( 29437642 )
2018
3
Impacts of long-term ragweed pollen load and other potential risk factors on ragweed pollen allergy among schoolchildren in Hungary. ( 29936806 )
2018
4
Cypress pollen allergy is responsible for two distinct phenotypes of allergic rhinitis different from other pollinosis. ( 29350019 )
2018
5
Ragweed Pollen Allergy: Burden, Characteristics, and Management of an Imported Allergen Source in Europe. ( 29788026 )
2018
6
Lolium perenne peptides for treatment of grass pollen allergy: AA randomized, double-blind, placebo-controlled clinical trial. ( 29030102 )
2018
7
Artemisia pollen allergy in China: Component-resolved diagnosis reveals allergic asthma patients have significant multiple allergen sensitization. ( 30155917 )
2018
8
Tell me about your hay fever: a qualitative investigation of allergic rhinitis management from the perspective of the patient. ( 29362452 )
2018
9
Prevalence of allergic sensitization, hay fever, eczema, and asthma in a longitudinal birth cohort. ( 30147342 )
2018
10
Erratum: "Climate Change and Future Pollen Allergy in Europe". ( 30007904 )
2018
11
Intralymphatic allergen immunotherapy against pollen allergy: A 3-year open follow-up study of 10 patients. ( 30021119 )
2018
12
A new molecular multiplex IgE assay for the diagnosis of pollen allergy in Mediterranean countries: A validation study. ( 30176088 )
2018
13
Component resolved analysis of ash pollen allergy in Bavaria. ( 30455718 )
2018
14
Estimating the causal effect of body mass index on hay fever, asthma and lung function using Mendelian randomization. ( 28675761 )
2018
15
Breast-feeding and risk of asthma, hay fever, and eczema. ( 29132959 )
2018
16
Associations of genetic determinants of serum vitamin B12 and folate concentrations with hay fever and asthma: a Mendelian randomization meta-analysis. ( 29249824 )
2018
17
Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope-based grass pollen allergy vaccine with allergen extract-based vaccines. ( 28576673 )
2017
18
Management of Grass Pollen Allergy with 5-Grass Pollen Tablet: Results of a 2-Year Real-Life Study. ( 28455783 )
2017
19
Efficacy of a leukotriene receptor antagonist for pediatric cedar pollen allergy complicated by asthma. ( 28928804 )
2017
20
Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy. ( 28689794 )
2017
21
Natural protective immunity against grass pollen allergy is maintained byA a diverse spectrum of response types. ( 28867457 )
2017
22
The current overuse and misuse of meta-analyses on sublingual immunotherapy: the case of grass pollen allergy. ( 27922912 )
2017
23
Association of eosinophilic esophagitis and food pollen allergy syndrome. ( 27856094 )
2017
24
Involvement of cross-reactive carbohydrate determinants-specific IgE in pollen allergy testing. ( 28154803 )
2017
25
Association Between Hay Fever and High Myopia in United States Adolescents and Adults. ( 26974535 )
2017
26
Patching it together: epicutaneous vaccination with heat-labile Escherichia coli toxin against birch pollen allergy. ( 27716934 )
2017
27
Thumb-sucking or nail-biting in childhood led to a reduction in atopic sensitisation but not asthma or hay fever. ( 27756755 )
2017
28
Exposure to Extreme Heat Events Is Associated with Increased Hay Fever Prevalence among Nationally Representative Sample of US Adults: 1997-2013. ( 27840238 )
2017
29
Age at onset and persistence of eczema are related to subsequent risk of asthma and hay fever from birth to 18 years of age. ( 28301056 )
2017
30
The Influence of Asthma and/or Hay Fever on Pregnancy: Data from the 1995 National Survey of Family Growth. ( 28550983 )
2017
31
Prenatal exposure to polychlorinated biphenyls and asthma, eczema/hay fever, and frequent ear infections. ( 29211547 )
2017
32
Register-based observational studies - who will endorse that maternal smoking lowers the odds for developing hay fever and eczema? ( 29744202 )
2017
33
Molecular cloning of plane pollen allergen PlaA aA 3 and its utility as diagnostic marker for peach associated plane pollen allergy. ( 26892183 )
2016
34
Efficacy and effectiveness of sublingual immunotherapy for grass pollen allergy: Reply to the letter of Marcucci F. ( 26778720 )
2016
35
Climate Change and Future Pollen Allergy in Europe. ( 27557093 )
2016
36
Biological Effects of Cloth Containing Specific Ore Powder in Patients with Pollen Allergy. ( 27660220 )
2016
37
Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection. ( 27568223 )
2016
38
Persistence of the IgE repertoire in birch pollen allergy. ( 27001158 )
2016
39
Mould and grass pollen allergy as risk factors for childhood asthma in Zaragoza, Spain. ( 27255475 )
2016
40
Urtica dioica pollen allergy: Clinical, biological, and allergomics analysis. ( 27788883 )
2016
41
Pollen information consumption as an indicator of pollen allergy burden. ( 26373744 )
2016
42
A biology-driven receptor model for daily pollen allergy risk in Korea based on Weibull probability density function. ( 27387542 )
2016
43
Efficacy and effectiveness of sublingual immunotherapy for grass pollen allergy. ( 27012472 )
2016
44
Relevance of a 5-grass sublingual tablet for immunotherapy of patients with grass pollen allergy in North America. ( 26813047 )
2016
45
Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy. ( 27650868 )
2016
46
The Smartphone: A Novel Diagnostic Tool in Pollen Allergy? ( 27326995 )
2016
47
Oocyst-Derived Extract of Toxoplasma Gondii Serves as Potent Immunomodulator in a Mouse Model of Birch Pollen Allergy. ( 27149118 )
2016
48
Hay fever in childhood, traits Neuroticism and Conscientiousness as independent predictors of the occurrence of hay fever in adulthood. ( 25836333 )
2016
49
Early farm residency and prevalence of asthma and hay fever in adults. ( 26377166 )
2016
50
Hay fever & homeopathy: a case series evaluation. ( 27211328 )
2016

Variations for Pollen Allergy

Expression for Pollen Allergy

Search GEO for disease gene expression data for Pollen Allergy.

Pathways for Pollen Allergy

Pathways related to Pollen Allergy according to GeneCards Suite gene sharing:

(show all 20)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.77 EPX ICAM1 IL13 IL3 IL4R IL5
2 12.58 IL13 IL3 IL4R IL5
3
Show member pathways
12.32 FOXP3 IL13 IL4R IL5
4
Show member pathways
12.1 IL13 IL3 IL4R IL5
5
Show member pathways
11.96 EPX FOXP3 ICAM1 IL13 IL3 IL4R
6
Show member pathways
11.9 IL3 IL5 PIK3CG
7
Show member pathways
11.78 IL13 IL5 PIK3CG
8 11.73 ICAM1 IL13 IL4R
9
Show member pathways
11.73 ICAM1 IL13 IL3 IL4R IL5
10 11.62 IL3 IL4R IL5
11 11.52 CD164 IL3 IL5 MPO
12 11.49 ICAM1 IL13 IL5
13
Show member pathways
11.43 FOXP3 IL3 IL5
14 11.11 IL4R IL5
15 11.09 IL13 IL5
16 10.97 IL13 IL3 IL5
17 10.96 IL13 IL5
18 10.92 FOXP3 IL13 IL4R IL5
19 10.9 IL13 IL3 IL5
20 10.73 ICAM1 MPO

GO Terms for Pollen Allergy

Cellular components related to Pollen Allergy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.56 CD164 EPX IL13 IL3 IL4R IL5
2 extracellular space GO:0005615 9.23 EPX ICAM1 IL13 IL3 IL4R IL5

Biological processes related to Pollen Allergy according to GeneCards Suite gene sharing:

(show all 15)
# Name GO ID Score Top Affiliating Genes
1 response to lipopolysaccharide GO:0032496 9.69 ICAM1 IL13 MPO
2 positive regulation of cold-induced thermogenesis GO:0120162 9.61 ADRB2 IL13 IL4R
3 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.58 ICAM1 IL3 IL5
4 negative regulation of endothelial cell apoptotic process GO:2000352 9.55 ICAM1 IL13
5 immune response GO:0006955 9.55 CD164 IL13 IL3 IL4R IL5
6 cytokine production GO:0001816 9.54 FOXP3 PIK3CG
7 hydrogen peroxide catabolic process GO:0042744 9.52 EPX MPO
8 positive regulation of interleukin-4 production GO:0032753 9.49 EPX FOXP3
9 positive regulation of macrophage activation GO:0043032 9.48 IL13 IL4R
10 negative regulation of interleukin-10 production GO:0032693 9.46 EPX FOXP3
11 positive regulation of mast cell degranulation GO:0043306 9.37 IL13 IL4R
12 positive regulation of immunoglobulin production GO:0002639 9.32 IL13 IL4R
13 negative regulation of interleukin-5 production GO:0032714 9.26 EPX FOXP3
14 cytokine-mediated signaling pathway GO:0019221 9.02 ICAM1 IL13 IL3 IL4R IL5
15 respiratory burst involved in defense response GO:0002679 8.96 MPO PIK3CG

Molecular functions related to Pollen Allergy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.13 IL13 IL3 IL5
2 peroxidase activity GO:0004601 8.62 EPX MPO

Sources for Pollen Allergy

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....